DNA image via www.shutterstock.com.
We should heed concerns about how private genetic data banks are used and accessed before we enable a system where the future of public genetic research lies in private hands.
Would you donate to a biobank?
How much privacy are we willing to give up in the name of cutting-edge science? And do we care about the kinds of research that will be done with our donations?
Our knowledge of diseases is growing exponentially, but turning knowledge into cures is proving to be a tricky business.
Why we must work out why some people respond exceptionally well to cancer treatments.
Phil and Pam Gradwell (to be)/Flickr
Some patients respond miraculously well to cancer treatment. It is high time we try to understand why.
Genomes don’t translate easily into an understanding of disease.
Big data is all well and good, but if we want medical breakthroughs, we'll need big theory too.
Who’s in charge once your biological material is out of your body?
Next-generation genomic research depends on study participants sharing their biological materials with scientists. But concerns over how that information is protected may hold some people back.
Effects may vary.
Why does the same medication, at the same dose, work well for some people, but not for others? The answer is in our genes.
Understanding the DNA of tumours allows researchers to target treatment to each individual.
Personalised medicine is based on the idea that by understanding the specific molecular code of a person’s disease, and particularly its genetic makeup, we can more accurately tailor treatment.
Where do you live?
Understanding genetics isn't enough to solve our health problems – we need to look at where people live, too.
BRCA1 and BRCA2 gene mutations prompted Angelina Jolie to have a preventative double mastectomy and surgery to remove both ovaries.
What if you could take a simple test to reveal your individual risk of developing a range of cancers and hundreds of other diseases?
Precision medicine delivers treatment based on the particular variant of the disease by taking the genetic make-up of the ill person into account.
Hidden among all the other announcements in last week’s State of the Union address by US President Barack Obama was a promise to fund a new “precision medicine initiative”. The president said it would…